This bill allows qualifying nonprofit organizations to receive full funding from the Green Acres Fund for projects on State-owned land without being required to provide matching funds. It changes existing rules that typically mandate nonprofits contribute their own money alongside state grants for development, repairs, or improvements of public property. The legislation specifically targets tax-exempt nonprofits working on facilities used for education, research, or recreation to help maintain and upgrade these sites. By removing the matching fund requirement, the bill aims to improve the repair and operation of State lands managed by these organizations.
This New Jersey bill introduces a new fee for employers who have at least 50 employees receiving Medicaid health coverage. The fee amount varies based on company size, charging $325, $525, or $725 per covered employee and their dependents depending on whether the employer has between 50-249, 250-499, or 500 or more Medicaid recipients. Employers with employees who have developmental, intellectual, or permanent physical disabilities are exempt from paying this charge. The revenue generated from these fees is intended to help cover the costs of the State Medicaid program.
This bill allows school districts in New Jersey to use leftover state funding for nonpublic school nursing services to pay for security services, and vice versa. Currently, districts must return any unused money from these specific programs to the state after the school year ends. The change permits districts to apply unspent funds from one program toward the costs of the other before a refund is required. This adjustment provides districts with more flexibility in managing state aid allocated for student safety and health care in private schools.
This bill appropriates $111.6 million in natural resource damages revenues to the New Jersey Department of Environmental Protection for habitat restoration, land acquisition, and oversight projects. The funds come from legal settlements with various corporations and are allocated across different water regions and specific sites like the Ciba-Geigy Superfund Site. The Department of Environmental Protection may distribute these funds through grants or loans to local governments and nonprofit organizations, with the ability to reallocate money among projects subject to budget approval and legislative notification.
This bill formally approves the Fiscal Year 2027 financial plan for the New Jersey Infrastructure Bank. The resolution authorizes the bank to proceed with funding loans and debt guarantees for eligible environmental projects, including clean water, drinking water, and stormwater management initiatives. By passing this measure, the Legislature ratifies the bank's budgetary strategy for the upcoming fiscal year as required by state law. The document does not alter the bank's operations but rather provides the necessary legislative consent for its planned financial activities.
This bill authorizes the New Jersey Infrastructure Bank to lend up to $3.85 billion to local governments and public water utilities for environmental infrastructure projects in fiscal year 2027. The funds are intended to help pay for the construction of facilities that manage water supply, wastewater treatment, and other environmental systems. Additionally, the legislation allows the bank to increase its lending capacity by including interest earned, administrative fees, and money transferred from specific state trust funds. These loans will be jointly managed by the Infrastructure Bank and the Department of Environmental Protection to ensure projects meet federal and state standards.
This bill directs the New Jersey Department of Environmental Protection to use specific state funds to finance environmental infrastructure projects in fiscal year 2027. The legislation authorizes the department to provide zero-interest or principal forgiveness loans to sponsors for clean water and drinking water initiatives, utilizing money from various revolving funds and federal grants. Additionally, it permits the transfer of funds between different state revolving accounts to address urgent public health threats and meet future financing needs. Ultimately, the act ensures that available capital is allocated to support essential water and wastewater infrastructure improvements through the state's lending programs.
This bill approves the Fiscal Year 2027 financial plan for the New Jersey Infrastructure Bank, a state agency that provides loans and debt guarantees for environmental projects. The resolution authorizes the bank to fund specific initiatives such as clean water, drinking water, stormwater management, and pollution control projects based on eligibility lists created by the Department of Environmental Protection. By passing this concurrent resolution, the Legislature formally validates the bank's budget and financing strategy for the upcoming fiscal year, allowing the agency to proceed with its authorized lending activities.
This bill authorizes the New Jersey Infrastructure Bank to lend $13.093 million to local governments for specific hazard mitigation and resilience projects in fiscal year 2027. The funds are designated for four approved initiatives in Jersey City, Brigantine, Highlands, and Manasquan, which include park resilience, living shorelines, flood mitigation, and coastal protection. To receive these loans, project sponsors must certify that their plans comply with existing emergency management laws and regulations, and the loans must be repaid within 30 years of completion. Additionally, the bill allows the bank to grow its lending capacity by using interest earned on loans and other program fees.
This bill requires New Jersey's Medicaid managed care organizations to automatically include lower-cost generic and biosimilar drugs on their formularies with better cost-sharing (like lower copays) when they are cheaper than the original brand drugs. It directly affects insurers managing Medicaid plans and their enrollees, ensuring patients pay less for equivalent treatments. Key provisions mandate that if a generic drug's price is lower than its reference brand at launch, insurers must list it with favorable cost-sharing and remove barriers like prior authorization. The bill does not force insurers to stop covering brand drugs but ensures cheaper alternatives are prioritized for cost savings. It applies only when cheaper options are available and respects medical appropriateness decisions by insurers.
